JP2001527382A - スタフィロコッカス・アウレウス由来のフェニルアラニル−tRNAシンセターゼ - Google Patents
スタフィロコッカス・アウレウス由来のフェニルアラニル−tRNAシンセターゼInfo
- Publication number
- JP2001527382A JP2001527382A JP52581197A JP52581197A JP2001527382A JP 2001527382 A JP2001527382 A JP 2001527382A JP 52581197 A JP52581197 A JP 52581197A JP 52581197 A JP52581197 A JP 52581197A JP 2001527382 A JP2001527382 A JP 2001527382A
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- polynucleotide
- trna synthetase
- sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9601096.2A GB9601096D0 (en) | 1996-01-19 | 1996-01-19 | Novel compounds |
| GBGB9615845.6A GB9615845D0 (en) | 1996-07-27 | 1996-07-27 | Novel compounds |
| GB9615845.6 | 1996-07-27 | ||
| GB9601096.2 | 1996-07-27 | ||
| PCT/GB1997/000153 WO1997026356A1 (en) | 1996-01-19 | 1997-01-17 | PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001527382A true JP2001527382A (ja) | 2001-12-25 |
| JP2001527382A5 JP2001527382A5 (cg-RX-API-DMAC10.html) | 2004-11-04 |
Family
ID=26308495
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52581197A Ceased JP2001527382A (ja) | 1996-01-19 | 1997-01-17 | スタフィロコッカス・アウレウス由来のフェニルアラニル−tRNAシンセターゼ |
| JP9525809A Pending JPH11504524A (ja) | 1996-01-19 | 1997-01-17 | スタフィロコッカス・アウレウスのヒスチジル−tRNAシンセターゼ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9525809A Pending JPH11504524A (ja) | 1996-01-19 | 1997-01-17 | スタフィロコッカス・アウレウスのヒスチジル−tRNAシンセターゼ |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US5948657A (cg-RX-API-DMAC10.html) |
| EP (4) | EP0785269A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2001527382A (cg-RX-API-DMAC10.html) |
| WO (2) | WO1997026356A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0785269A1 (en) * | 1996-01-19 | 1997-07-23 | Smithkline Beecham Plc | Histidyl-tRNA synthetase of Staphylococcus aureus |
| EP0916728A1 (en) * | 1997-10-17 | 1999-05-19 | Smithkline Beecham Corporation | Phenyl alanyl tRNA synthetase [EC 6.1.1.20] alpha subunit family, pheS (alpha), from Streptococcus pneumoniae |
| CN102105164A (zh) | 2008-06-11 | 2011-06-22 | Atyr医药公司 | 酪氨酰-trna合成酶多肽的血小板生成活性 |
| EP2310498A1 (en) | 2008-06-26 | 2011-04-20 | Atyr Pharma, Inc. | Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activities |
| ES2552773T3 (es) | 2009-02-27 | 2015-12-02 | Atyr Pharma, Inc. | Motivos estructurales de polipéptidos asociados con la actividad de señalización celular |
| JP5730280B2 (ja) | 2009-03-16 | 2015-06-03 | パング バイオファーマ リミテッド | 非カノニカル生物学的活性を有するヒスチジル−tRNAシンテターゼスプライスバリアントを含む組成物および方法 |
| WO2010120509A2 (en) | 2009-03-31 | 2010-10-21 | Atyr Pharma, Inc. | Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities |
| ES2535951T3 (es) | 2009-12-11 | 2015-05-19 | Atyr Pharma, Inc. | Histidil ARNt sintetasas para reducir la inflamación |
| US8828395B2 (en) | 2009-12-11 | 2014-09-09 | Atyr Pharma, Inc. | Antibodies that bind tyrosyl-tRNA synthetases |
| CA2797093C (en) | 2010-04-26 | 2019-10-29 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
| CA2797362C (en) | 2010-04-27 | 2020-12-08 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases |
| CA2797259C (en) | 2010-04-27 | 2020-09-29 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases |
| WO2011139853A2 (en) | 2010-04-28 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
| US8986680B2 (en) | 2010-04-29 | 2015-03-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases |
| EP2563383B1 (en) | 2010-04-29 | 2017-03-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
| WO2011139986A2 (en) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
| CA2797977C (en) | 2010-05-03 | 2019-08-20 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases |
| CN103140233B (zh) | 2010-05-03 | 2017-04-05 | Atyr 医药公司 | 与甲硫氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现 |
| AU2011248357B2 (en) | 2010-05-03 | 2017-02-23 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-tRNA synthetases |
| US9062301B2 (en) | 2010-05-04 | 2015-06-23 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-tRNA synthetases |
| EP2566499B1 (en) | 2010-05-04 | 2017-01-25 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
| CA2799197C (en) | 2010-05-14 | 2019-10-29 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
| US9034598B2 (en) | 2010-05-17 | 2015-05-19 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
| AU2011258106B2 (en) | 2010-05-27 | 2017-02-23 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases |
| CN103118694B (zh) | 2010-06-01 | 2016-08-03 | Atyr医药公司 | 与赖氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现 |
| US8999321B2 (en) | 2010-07-12 | 2015-04-07 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
| EP2593126B1 (en) | 2010-07-12 | 2017-09-20 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| CA2804278C (en) | 2010-07-12 | 2021-07-13 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| JP6116479B2 (ja) | 2010-07-12 | 2017-04-19 | エータイアー ファーマ, インコーポレイテッド | グリシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| JP5964304B2 (ja) | 2010-08-25 | 2016-08-03 | エータイアー ファーマ, インコーポレイテッド | チロシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| CA2812795C (en) | 2010-10-06 | 2021-08-31 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases |
| WO2013022982A2 (en) | 2011-08-09 | 2013-02-14 | Atyr Pharma, Inc. | Pegylated tyrosyl-trna synthetase polypeptides |
| US9816084B2 (en) | 2011-12-06 | 2017-11-14 | Atyr Pharma, Inc. | Aspartyl-tRNA synthetases |
| WO2013086228A1 (en) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Pegylated aspartyl-trna synthetase polypeptides |
| CN104220461A (zh) | 2011-12-29 | 2014-12-17 | Atyr医药公司 | 天冬氨酰-tRNA合成酶-FC缀合物 |
| EP2814514B1 (en) | 2012-02-16 | 2017-09-13 | Atyr Pharma, Inc. | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
| CN114717206A (zh) | 2013-03-15 | 2022-07-08 | Atyr 医药公司 | 组氨酰-trna合成酶-fc缀合物 |
| ES2994451T3 (en) | 2017-04-20 | 2025-01-24 | Atyr Pharma Inc | Compositions for treating lung inflammation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| AU6958194A (en) * | 1993-05-28 | 1994-12-20 | Massachusetts Institute Of Technology | Trna binding-dependent inhibition of microbial pathogen growth |
| GB9320563D0 (en) * | 1993-10-06 | 1993-11-24 | Zeneca Ltd | Assay procedure and application in identification of herbicides |
| US5561054A (en) * | 1995-05-15 | 1996-10-01 | Board Of Trustees Operating Michigan State University | Recombinant asparaginyl-tRNA synthetase from the human filarial parasite, brugia malayi |
| WO1997005126A1 (en) * | 1995-07-29 | 1997-02-13 | Smithkline Beecham Plc | Mupirocinsulfamates with antibacterial activity |
| US6737248B2 (en) * | 1996-01-05 | 2004-05-18 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
| EP0785269A1 (en) * | 1996-01-19 | 1997-07-23 | Smithkline Beecham Plc | Histidyl-tRNA synthetase of Staphylococcus aureus |
-
1997
- 1997-01-17 EP EP97300318A patent/EP0785269A1/en not_active Withdrawn
- 1997-01-17 JP JP52581197A patent/JP2001527382A/ja not_active Ceased
- 1997-01-17 WO PCT/GB1997/000153 patent/WO1997026356A1/en not_active Ceased
- 1997-01-17 EP EP02016734A patent/EP1288298A3/en not_active Withdrawn
- 1997-01-17 EP EP02016735A patent/EP1275720A3/en not_active Withdrawn
- 1997-01-17 JP JP9525809A patent/JPH11504524A/ja active Pending
- 1997-01-17 US US08/913,581 patent/US5948657A/en not_active Expired - Lifetime
- 1997-01-17 EP EP97300311A patent/EP0785262A1/en not_active Withdrawn
- 1997-01-17 WO PCT/GB1997/000151 patent/WO1997026354A1/en not_active Ceased
- 1997-01-17 US US08/785,052 patent/US5756329A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1288298A2 (en) | 2003-03-05 |
| EP0785262A1 (en) | 1997-07-23 |
| WO1997026354A1 (en) | 1997-07-24 |
| EP1288298A3 (en) | 2003-03-12 |
| US5948657A (en) | 1999-09-07 |
| EP1275720A2 (en) | 2003-01-15 |
| WO1997026356A1 (en) | 1997-07-24 |
| EP1275720A3 (en) | 2003-04-16 |
| EP0785269A1 (en) | 1997-07-23 |
| JPH11504524A (ja) | 1999-04-27 |
| US5756329A (en) | 1998-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH11506019A (ja) | スタフィロコッカス・アウレウスのチロシル−tRNAシンセターゼ | |
| US5756329A (en) | DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus | |
| JPH11504820A (ja) | スタフィロコッカス・アウレウスのスレオニル−tRNAシンセターゼ | |
| JP2000509975A (ja) | 新規化合物 | |
| JP2000509262A (ja) | 新規化合物 | |
| JPH1175861A (ja) | 新規糖キナーゼ | |
| JPH11503619A (ja) | スタフィロコッカス・アウレウスのメチオニル−tRNAシンセターゼ | |
| JPH11253179A (ja) | 新規グルコサミニダ―ゼ | |
| JPH10191987A (ja) | 新規3−デヒドロキナ酸シンターゼ | |
| JPH11506618A (ja) | スタフィロコッカス・アウレウスの新規バリル−tRNAシンセターゼ | |
| JPH11503922A (ja) | スタフィロコッカス・アウレウスのアラニル−tRNAシンセターゼ | |
| JPH11503331A (ja) | スタフィロコッカス・アウレウス由来のグルタミル−tRNAシンセターゼ | |
| JP2000509261A (ja) | 新規化合物 | |
| JP2002504302A (ja) | ribG | |
| JPH11502725A (ja) | スタフィロコッカス・アウレウス由来の新規トリプトファニル−tRNAシンセターゼ | |
| JPH10313873A (ja) | 新規DivIB | |
| JPH10313879A (ja) | 新規化合物 | |
| JPH11502425A (ja) | スタフィロコッカス・アウレウスのアスパラギニルtRNAシンセターゼ | |
| JP2002540758A (ja) | Ama | |
| JPH11502422A (ja) | スタフィロコッカス・アウレウスのグリシル−tRNAシンセターゼ | |
| JP2002253279A (ja) | 新規化合物 | |
| JP2002506826A (ja) | nrdG | |
| JPH11180A (ja) | ヒスチジンキナーゼ | |
| JPH11262392A (ja) | 新規MurE | |
| JP2002504321A (ja) | 新規pgsA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20031211 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20031211 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070522 |
|
| A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20071010 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20071120 |